# Perioperative Topical Nepafenac After Epiretinal Membrane Surgery

> **NCT07736690** · PHASE4 · COMPLETED · sponsor: **Ankara Yildirim Beyazıt University** · enrollment: 60 (actual)

## Conditions studied

- Epiretinal Membrane
- Macular Pucker

## Interventions

- **DRUG:** Nepafenac 0.1% Ophthalmic Suspension
- **PROCEDURE:** Pars Plana Vitrectomy With Epiretinal Membrane and Internal Limiting Membrane Peeling

## Key facts

- **NCT ID:** NCT07736690
- **Lead sponsor:** Ankara Yildirim Beyazıt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736690, "Perioperative Topical Nepafenac After Epiretinal Membrane Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*